Login / Signup

FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy.

Jee Young ParkPil-Jong KimSu-Jin ShinJae-Lyun LeeYong Mee ChoHeounjeong Go
Published in: Histopathology (2020)
FGFR1 and c-MYC may be involved in tumour angiogenesis and FGFR1 may represent a promising therapeutic target in metastatic CCRCC.
Keyphrases
  • metastatic renal cell carcinoma
  • squamous cell carcinoma
  • small cell lung cancer
  • endothelial cells
  • vascular endothelial growth factor
  • wound healing